SGTI Revenue third quarter 2013 Y/Y Growth Comment
Shengtai Pharmaceutical, Inc. achieved in the third quarter 2013, above Company average Revenue growth of 24.93% year on year, to $ 49.72 millions.
Looking into third quarter 2013 results within Biotechnology & Pharmaceuticals industry 16 other companies have achieved higher Revenue growth. While Shengtai Pharmaceutical, Inc.' s Revenue rise of 24.93% ranks overall at the positon no. 657 in the third quarter 2013.
Revenue by Quarter for the Fiscal Years 2010, 2011, 2012, 2013
Shengtai Pharmaceutical,'s Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
31.51 %
4.54 %
-22.43 %
(Dec 31 2012)
SGTI's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2013 Shengtai Pharmaceutical, Inc. disclosed fall in Revenue from the second quarter by -22.43% to $ 49.72 millions, from $ 64.10 millions achived in the previous reporting period.
But that's not important problem, as Shengtai Pharmaceutical,'s Revenue generally seem to plunge in this quarter.
Within Biotechnology & Pharmaceuticals industry 23 other companies have achieved higher Revenue quarter on quarter growth. While Shengtai Pharmaceutical,'s Revenue growth quarter on quarter, overall rank is 2127.
In the III. Quarter 2013 Shengtai Pharmaceutical, Inc. disclosed fall in Revenue from the second quarter by -22.43% to $ 49.72 millions, from $ 64.10 millions achived in the previous reporting period.
But that's not important problem, as Shengtai Pharmaceutical,'s Revenue generally seem to plunge in this quarter.
Within Biotechnology & Pharmaceuticals industry 23 other companies have achieved higher Revenue quarter on quarter growth. While Shengtai Pharmaceutical,'s Revenue growth quarter on quarter, overall rank is 2127.
Shengtai Pharmaceutical,'s 12 Months Revenue Growth Year on Year
With 31.47% annual Revenue growth, Shengtai Pharmaceutical, Inc. would report a record annual Revenue rise if the fiscal year would end on Mar 31 2013.
In the Healthcare sector 158 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 1261.
With 31.47% annual Revenue growth, Shengtai Pharmaceutical, Inc. would report a record annual Revenue rise if the fiscal year would end on Mar 31 2013.
In the Healthcare sector 158 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 1261.
About Shengtai Pharmaceutical, Revenue Growth Rates (SGTI), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.